13F-HR filed by CAXTON CORP
CAXTON CORP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 11 holding rows worth $4,279,210.
- Accession
- 0000919574-26-000956
- Filer
- CIK 1388551
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 11 entries on the cover page, a total value of $4,279,210 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,279,210 with VALUE read as dollars as filed, 13F file number 028-15293. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR GOLD TR | 78463V107 | GOLD SHS | 6,964 | $2,759,901 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| Berkshire Hathaway Inc | 084670702 | COM | 710 | $356,771 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 8,919 | $292,194 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| MIND MEDICINE MINDMED INC | 60255C885 | COM NEW | 15,688 | $210,058 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 18,773 | $176,468 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 29,495 | $158,386 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| LEXEO THERAPEUTICS INC | 52886X107 | COMMON STOCK | 13,943 | $138,453 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 15,557 | $62,227 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | COMMON STOCK | 28,453 | $58,328 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| SAB BIOTHERAPEUTICS INC | 78397T202 | COMMON STOCK | 10,527 | $39,371 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 18,403 | $27,053 | dollars as filed | The filing omitted confidential holdings, a later amendment may add them. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-26-000956 | this filing | 2026-02-13 | acceptance time not in the bulk data set |